大剂量等渗盐水鼻腔冲洗治疗急性鼻窦炎的随机对照研究
结果显示两组总体各项结局改善无差异,亚组分析中仅普通感冒亚组在鼻部子评分和联合症状评分上从冲洗获益。
要点
- 大剂量等渗盐水冲洗作为附加治疗对全体ARS患者未显示额外获益。
- 普通感冒亚组冲洗后鼻部子评分和联合症状评分改善优于对照组。
- 临床可考虑对普通感冒型ARS患者选择性使用大剂量等渗盐水冲洗。
核心结论
- 附加大剂量正压等渗盐水冲洗并非对所有急性鼻窦炎患者均带来额外获益。
- 冲洗对生活质量和鼻部症状的获益仅在普通感冒亚组中观察到。
研究设计与样本
- 平行随机对照试验,在三级医院开展。
- 冲洗组在标准治疗基础上接受0.9%盐水冲洗,每日2次,使用250ml挤压瓶;无冲洗组仅接受标准治疗。
- 在基线、1周和2周时评估生活质量、鼻部子评分、症状评分、内镜评分和治愈率。
主要发现
- 两组均显示改善,但各项结局的改善程度在两组间无差异。
- 按ARS亚型分层分析显示,普通感冒亚组冲洗组鼻部子评分改善优于对照:1周时组间平均差-4.15(95%CI -7.49, -0.80),2周时-5.23(95%CI -9.69, -0.78)。
- 普通感冒亚组冲洗组联合症状评分改善优于对照:1周时组间平均差-5.35(95%CI -10.55, -0.14),2周时-8.02(95%CI -14.36, -1.70)。
关键数值与推荐
- 冲洗方案:0.9%盐水,每日2次,250ml挤压瓶,正压冲洗。
- 普通感冒亚组鼻部子评分组间平均差:1周-4.15(95%CI -7.49, -0.80),2周-5.23(95%CI -9.69, -0.78)。
- 普通感冒亚组联合症状评分组间平均差:1周-5.35(95%CI -10.55, -0.14),2周-8.02(95%CI -14.36, -1.70)。
临床怎么用
- 不应将大剂量等渗盐水冲洗作为所有急性鼻窦炎患者的常规附加治疗。
- 对于普通感冒亚型的急性鼻窦炎患者,可考虑使用大剂量正压等渗盐水冲洗以改善鼻部症状和生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare the effects of nasal saline irrigation (large volume, positive pressure isotonic saline) in addition to standard treatment in patients with acute rhinosinusitis (ARS). METHODS: This parallel, randomized controlled trial was conducted at a tertiary hospital. The adult patients with ARS (age ≥18 years) were randomly assigned to two groups. The irrigation group received 0.9% saline irrigation twice daily, using a 250-ml squeeze bottle, in addition to standard treatment. The no-irrigation group received standard treatment only. Patients were evaluated at baseline, 1 week, and 2 weeks. The quality of life, rhinologic subscore, symptom score, endoscopy score, and cure rate were compared. RESULTS: Sixty-one patients (30: irrigation, 31: no-irrigation) were enrolled. There were 17 males and 44 females. The mean age was 41.06 years. Although both groups showed improvements, the improvement of each outcome was not different between the groups. Subgroup analysis by ARS subtype showed benefits of irrigation in the common cold subgroup; the improvements that were greater than control included: rhinologic subscore, intergroup mean difference -4.15 [95% confidence interval (CI), -7.49, -0.80] at 1 week and -5.23 [95% CI, -9.69, -0.78] at 2 weeks; combined symptom score -5.35 [95% CI, -10.55, -0.14] at 1 week and -8.02 [95%CI, -14.36, -1.70] at 2 weeks. CONCLUSION: The add-on isotonic nasal saline irrigation using a large volume, positive pressure device did not add benefits equally for all ARS patients. The benefits of irrigation on quality of life and nasal symptoms were only observed in the common cold patient subgroup.
引用
- Chitsuthipakorn W, Thanaphiphatsatja A, Doungbuppha P, et al. Effects of large volume, isotonic nasal saline irrigation for acute rhinosinusitis: a randomized controlled study. Int Forum Allergy Rhinol. 2021. PMID: 33960674. doi:10.1002/alr.22807
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。